title: O-GlcNAc expression in developing and ageing mouse brain.
abstract: In order to understand whether there is a specific role for the posttranslational N-acetylglucosamine modification linked O-glycosidically (O-GlcNAc) to serine and threonine residues of proteins during development and/or ageing of the brain, we investigated the O-GlcNAc expression of early postnatal cerebellar neurons as well as of mouse brain of different ages. In all cells either in culture or of cryosections mainly the nuclei and nuclear membranes were stained with an O-GlcNAc specific monoclonal antibody. In cerebellar neurons in culture the level of expression could be manipulated by directly interfering with either the biosynthesis of GlcNAc or the removal of O-GlcNAc from proteins confirming the dynamic nature of this protein modification. O-GlcNAc was ubiquitously expressed in mouse brains from embryonic day 10 until late adulthood with some variations in expression strength from cell to cell. In addition, no significant difference in O-GlcNAc expression of subcellular fractions from brains of mice which age at an accelerated rate could be detected compared to normal mice. Taken together these observations support the view that the O-GlcNAc modification has important functional roles for physiological processes of neural cell throughout development, in adulthood and ageing.
authors.affiliation: Department of Biochemistry, Institute for Animal Anatomy, University of Bonn, Katzenburgweg 9a, 53115 Bonn, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Rex-Mathes
authors.forename: S
authors.initials: S
authors.lastname: Werner
authors.forename: D
authors.initials: D
authors.lastname: Strutas
authors.forename: L S
authors.initials: LS
authors.lastname: Griffith
authors.forename: C
authors.initials: C
authors.lastname: Viebahn
authors.forename: K
authors.initials: K
authors.lastname: Thelen
authors.forename: B
authors.initials: B
authors.lastname: Schmitz
mesh_terms: D000116:Acetylgalactosamine / Q000378:metabolism; D000117:Acetylglucosamine / Q000031:analogs & derivatives* / Q000378:metabolism* / Q000494:pharmacology; D000375:Aging; D000818:Animals; D000911:Antibodies, Monoclonal; D015153:Blotting, Western; D001921:Brain / Q000254:growth & development / Q000378:metabolism*; D002478:Cells, Cultured; D002531:Cerebellum / Q000378:metabolism; D004622:Embryo, Mammalian; D004791:Enzyme Inhibitors / Q000494:pharmacology; D019085:Fluorescent Antibody Technique, Direct; D015870:Gene Expression; D007150:Immunohistochemistry; D051379:Mice; D008807:Mice, Inbred BALB C; D008815:Mice, Inbred Strains; D009474:Neurons / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D010091:Oximes / Q000494:pharmacology; D048448:Phenylcarbamates; D011485:Protein Binding; D013379:Substrate Specificity
chemical_list: D000911:Antibodies, Monoclonal; D004791:Enzyme Inhibitors; D010091:Oximes; D048448:Phenylcarbamates; C068836:N-acetylglucosaminono-1,5-lactone O-(phenylcarbamoyl)oxime; D000116:Acetylgalactosamine; D000117:Acetylglucosamine